Modulation of the Ca2+ conductance of nicotinic acetylcholine receptors by Lypd6

European Neuropsychopharmacology

Volumn 19, Issue 9, 2009, Pages 670-681

  Darvas, Martin ^a   Morsch, Marco ^a   Racz, Ildiko ^a   Ahmadi, Seifollah ^a   Swandulla, Dieter ^a   Zimmer, Andreas ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Allosteric modulator; Behavior; Electrophysiology; Ion selectivity; Receptor channel; Transgenic mice

Indexed keywords

CALCIUM ION; CELL PROTEIN; NICOTINE; NICOTINIC RECEPTOR; PROTEIN LYPD6; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; CALCIUM; LYPD6 PROTEIN, MOUSE; NERVE PROTEIN;

AMINO ACID SEQUENCE; ANALGESIC ACTIVITY; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AROUSAL; ARTICLE; CALCIUM CONDUCTANCE; CALCIUM CURRENT; CALCIUM TRANSPORT; CHOLINERGIC SYSTEM; CONTROLLED STUDY; GENE OVEREXPRESSION; HYPOALGESIA; LOCOMOTION; MOUSE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEQUENCE ANALYSIS; TRANSGENIC MOUSE; TRIGEMINAL NERVE; WESTERN BLOTTING; ANIMAL; CENTRAL NERVOUS SYSTEM; DRUG EFFECT; FEMALE; GENE EXPRESSION; GENETICS; MALE; METABOLISM; MOLECULAR GENETICS; PATCH CLAMP; PHYSIOLOGY; TRIGEMINUS GANGLION;

AMINO ACID SEQUENCE; ANIMALS; BEHAVIOR, ANIMAL; CALCIUM; CENTRAL NERVOUS SYSTEM; FEMALE; GENE EXPRESSION; MALE; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; PATCH-CLAMP TECHNIQUES; RECEPTORS, NICOTINIC; TRIGEMINAL GANGLION;

EID: 67650691159     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2009.03.007     Document Type: Article

References (53)

1. Abreu-Villaca Y., Queiroz-Gomes FDO E., Dal Monte A.P., Filgueiras C.C., and Manhaes A.C. Individual differences in novelty-seeking behavior but not in anxiety response to a new environment can predict nicotine consumption in adolescent C57BL/6 mice. Behav. Brain Res. 167 (2006) 175-182
2. Adermann K., Wattler F., Wattler S., Heine G., Meyer M., Forssmann W.G., and Nehls M. Structural and phylogenetic characterization of human SLURP-1, the first secreted mammalian member of the Ly-6/uPAR protein superfamily. Protein Sci. 8 (1999) 810-819
3. Arredondo J., Chernyavsky A.I., Jolkovsky D.L., Webber R.J., and Grando S.A. SLURP-2: A novel cholinergic signaling peptide in human mucocutaneous epithelium. J. Cell. Physiol. 208 (2006) 238-245
4. Arredondo J., Chernyavsky A.I., Webber R.J., and Grando S.A. Biological effects of SLURP-1 on human keratinocytes. J. Invest. Dermatol. 125 (2005) 1236-1241
5. Behrendt N., Ploug M., Patthy L., Houen G., Blasi F., and Dano K. The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator. J. Biol. Chem. 266 (1991) 7842-7847
6. Bilkei-Gorzo A., Racz I., Michel K., Darvas M., Maldonado R., and Zimmer A. A common genetic predisposition to stress sensitivity and stress-induced nicotine craving. Biol. Psychiatry 63 (2008) 164-171
7. Bilkei-Gorzo A., Racz I., Michel K., Zimmer A., Klingmuller D., and Zimmer A. Behavioral phenotype of pre-proenkephalin-deficient mice on diverse congenic backgrounds. Psychopharmacology (Berl) 176 (2004) 343-352
8. Champtiaux N., and Changeux J.P. Knockout and knockin mice to investigate the role of nicotinic receptors in the central nervous system. Prog. Brain Res. 145 (2004) 235-251
9. Chimienti F., Hogg R.C., Plantard L., Lehmann C., Brakch N., Fischer J., Huber M., Bertrand D., and Hohl D. Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of Mal de Meleda. Hum. Mol. Genet. 12 (2003) 3017-3024
10. Curtis L., Buisson B., Bertrand S., and Bertrand D. Potentiation of human alpha4beta2 neuronal nicotinic acetylcholine receptor by estradiol. Mol. Pharmacol. 61 (2002) 127-135
11. Dani J.A. Overview of nicotinic receptors and their roles in the central nervous system. Biol. Psychiatry 49 (2001) 166-174
12. Decker M.W., Anderson D.J., Brioni J.D., Donnelly-Roberts D.L., Kang C.H., O'Neill A.B., Piattoni-Kaplan M., Swanson S., and Sullivan J.P. Erysodine, a competitive antagonist at neuronal nicotinic acetylcholine receptors. Eur. J. Pharmacol. 280 (1995) 79-89
13. Decker M.W., Rueter L.E., and Bitner R.S. Nicotinic acetylcholine receptor agonists: a potential new class of analgesics. Curr. Top. Med. Chem. 4 (2004) 369-384
14. Descarries L., Gisiger V., and Steriade M. Diffuse transmission by acetylcholine in the CNS. Prog. Neurobiol. 53 (1997) 603-625
15. Dittgen T., Nimmerjahn A., Komai S., Licznerski P., Waters J., Margrie T.W., Helmchen F., Denk W., Brecht M., and Osten P. Lentivirus-based genetic manipulations of cortical neurons and their optical and electrophysiological monitoring in vivo. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 18206-18211
16. Everitt B.J., and Robbins T.W. Central cholinergic systems and cognition. Annu. Rev. Psychol. 48 (1997) 649-684
17. Fleming T.J., O'Huigin C., and Malek T.R. Characterization of two novel Ly-6 genes. Protein sequence and potential structural similarity to alpha-bungarotoxin and other neurotoxins. J. Immunol. 150 (1993) 5379-5390
18. 2+ permeability of nicotinic acetylcholine receptors from rat dorsal root ganglion neurones. J. Physiol. 565 (2005) 219-228
19. Genzen J.R., van Cleve W., and McGehee D.S. Dorsal root ganglion neurons express multiple nicotinic acetylcholine receptor subtypes. J. Neurophysiol. 86 (2001) 1773-1782
20. Geyer M.A., Mcilwain K.L., and Paylor R. Mouse genetic models for prepulse inhibition: an early review. Mol. Psychiatry 7 (2002) 1039-1053
21. Grailhe R., Waeber C., Dulawa S.C., Hornung J.P., Zhuang X., Brunner D., Geyer M.A., and Hen R. Increased exploratory activity and altered response to LSD in mice lacking the 5-HT(5A) receptor. Neuron 22 (1999) 581-591
22. Gumley T.P., Mckenzie I.F., and Sandrin M.S. Tissue expression, structure and function of the murine Ly-6 family of molecules. Immunol. Cell Biol. 73 (1995) 277-296
23. Gustincich S., Batalov S., Beisel K.W., Bono H., Carninci P., Fletcher C.F., Grimmond S., Hirokawa N., Jarvis E.D., Jegla T., Kawasawa Y., Lemieux J., Miki H., Raviola E., Teasdale R.D., Tominaga N., Yagi K., Zimmer A., Hayashizaki Y., and Okazaki Y. Analysis of the mouse transcriptome for genes involved in the function of the nervous system. Genome Res. 13 (2003) 1395-1401
24. Hanninen A., Jaakkola I., Salmi M., Simell O., and Jalkanen S. Ly-6C regulates endothelial adhesion and homing of CD8(+) T cells by activating integrin-dependent adhesion pathways. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 6898-6903
25. Hefft S., Hulo S., Bertrand D., and Muller D. Synaptic transmission at nicotinic acetylcholine receptors in rat hippocampal organotypic cultures and slices. J. Physiol. 515 Pt 3 (1999) 769-776
26. Hogarth P.M., Mckenzie I.F., Sutton V.R., Curnow K.M., Lee B.K., and Eicher E.M. Mapping of the mouse Ly-6, Xp-14, and Gdc-1 loci to chromosome 15. Immunogenetics 25 (1987) 21-27
27. Hogg R.C., Buisson B., and Bertrand D. Allosteric modulation of ligand-gated ion channels. Biochem. Pharmacol. 70 (2005) 1267-1276
28. Hurst R.S., Hajos M., Raggenbass M., Wall T.M., Higdon N.R., Lawson J.A., Rutherford-Root K.L., Berkenpas M.B., Hoffmann W.E., Piotrowski D.W., Groppi V.E., Allaman G., Ogier R., Bertrand S., Bertrand D., and Arneric S.P. A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization. J. Neurosci. 25 (2005) 4396-4405
29. Ibanez-Tallon I., Miwa J.M., Wang H.L., Adams N.C., Crabtree G.W., Sine S.M., and Heintz N. Novel modulation of neuronal nicotinic acetylcholine receptors by association with the endogenous prototoxin lynx1. Neuron 33 (2002) 893-903
30. Ibanez-Tallon I., Wen H., Miwa J.M., Xing J., Tekinay A.B., Ono F., Brehm P., and Heintz N. Tethering naturally occurring peptide toxins for cell-autonomous modulation of ion channels and receptors in vivo. Neuron 43 (2004) 305-311
31. Krause R.M., Buisson B., Bertrand S., Corringer P.J., Galzi J.L., Changeux J.P., and Bertrand D. Ivermectin: a positive allosteric effector of the alpha7 neuronal nicotinic acetylcholine receptor. Mol. Pharmacol. 53 (1998) 283-294
32. Lena C., Changeux J.P., and Mulle C. Evidence for "preterminal" nicotinic receptors on GABAergic axons in the rat interpeduncular nucleus. J. Neurosci. 13 (1993) 2680-2688
33. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 (2001) 402-408
34. Maelicke A., Samochocki M., Jostock R., Fehrenbacher A., Ludwig J., Albuquerque E.X., and Zerlin M. Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease. Biol. Psychiatry 49 (2001) 279-288
35. Mallya M., Campbell R.D., and Aguado B. Characterization of the five novel Ly-6 superfamily members encoded in the MHC, and detection of cells expressing their potential ligands. Protein Sci. 15 (2006) 2244-2256
36. Marubio L.M., Del Mar Arroyo-Jimenez M., Cordero-Erausquin M., Lena C., Le Novere N., de Kerchove D'Exaerde A., Huchet M., Damaj M.I., and Changeux J.P. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature 398 (1999) 805-810
37. Maskos U., Molles B.E., Pons S., Besson M., Guiard B.P., Guilloux J.P., Evrard A., Cazala P., Cormier A., Mameli-Engvall M., Dufour N., Cloez-Tayarani I., Bemelmans A.P., Mallet J., Gardier A.M., David V., Faure P., Granon S., and Changeux J.P. Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature 436 (2005) 103-107
38. McGehee D.S., Heath M.J., Gelber S., Devay P., and Role L.W. Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science 269 (1995) 1692-1696
39. Miwa J.M., Ibanez-Tallon I., Crabtree G.W., Sanchez R., Sali A., Role L.W., and Heintz N. lynx1, an endogenous toxin-like modulator of nicotinic acetylcholine receptors in the mammalian CNS. Neuron 23 (1999) 105-114
40. Miwa J.M., Stevens T.R., King S.L., Caldarone B.J., Ibanez-Tallon I., Xiao C., Fitzsimonds R.M., Pavlides C., Lester H.A., Picciotto M.R., and Heintz N. The prototoxin lynx1 acts on nicotinic acetylcholine receptors to balance neuronal activity and survival in vivo. Neuron 51 (2006) 587-600
41. Okazaki Y., Furuno M., Kasukawa T., Adachi J., Bono H., Kondo S., Nikaido I., Osato N., Saito R., Suzuki H., Yamanaka I., Kiyosawa H., Yagi K., Tomaru Y., Hasegawa Y., Nogami A., Schonbach C., Gojobori T., Baldarelli R., Hill D.P., Bult C., Hume D.A., Quackenbush J., Schriml L.M., Kanapin A., Matsuda H., Batalov S., Beisel K.W., Blake J.A., Bradt D., Brusic V., Chothia C., Corbani L.E., Cousins S., Dalla E., Dragani T.A., Fletcher C.F., Forrest A., Frazer K.S., Gaasterland T., Gariboldi M., Gissi C., Godzik A., Gough J., Grimmond S., Gustincich S., Hirokawa N., Jackson I.J., Jarvis E.D., Kanai A., Kawaji H., Kawasawa Y., Kedzierski R.M., King B.L., Konagaya A., Kurochkin I.V., Lee Y., Lenhard B., Lyons P.A., Maglott D.R., Maltais L., Marchionni L., McKenzie L., Miki H., Nagashima T., Numata K., Okido T., Pavan W.J., Pertea G., Pesole G., Petrovsky N., Pillai R., Pontius J.U., Qi D., Ramachandran S., Ravasi T., Reed J.C., Reed D.J., Reid J., Ring B.Z., Ringwald M., Sandelin A., Schneider C., Semple C.A., Setou M., Shimada K., Sultana R., Takenaka Y., Taylor M.S., Teasdale R.D., Tomita M., Verardo R., Wagner L., Wahlestedt C., Wang Y., Watanabe Y., Wells C., Wilming L.G., Wynshaw-Boris A., Yanagisawa M., et al. Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature 420 (2002) 563-573
42. Picciotto M.R., Caldarone B.J., King S.L., and Zachariou V. Nicotinic receptors in the brain. Links between molecular biology and behavior. Neuropsychopharmacology 22 (2000) 451-465
43. Picciotto M.R., Zoli M., Lena C., Bessis A., Lallemand Y., Le Novere N., Vincent P., Pich E.M., Brulet P., and Changeux J.P. Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature 374 (1995) 65-67
44. Ploug M., and Ellis V. Structure-function relationships in the receptor for urokinase-type plasminogen activator. Comparison to other members of the Ly-6 family and snake venom alpha-neurotoxins. FEBS Lett. 349 (1994) 163-168
45. Racz I., Schutz B., Abo-Salem O.M., and Zimmer A. Visceral, inflammatory and neuropathic pain in glycine receptor alpha 3-deficient mice. Neuroreport 16 (2005) 2025-2028
46. Roerig B., Nelson D.A., and Katz L.C. Fast synaptic signaling by nicotinic acetylcholine and serotonin 5-HT3 receptors in developing visual cortex. J. Neurosci. 17 (1997) 8353-8362
47. Rubinson D.A., Dillon C.P., Kwiatkowski A.V., Sievers C., Yang L., Kopinja J., Rooney D.L., Ihrig M.M., McManus M.T., Gertler F.B., Scott M.L., and van Parijs L. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 33 (2003) 401-406
48. Stevens K.E., and Wear K.D. Normalizing effects of nicotine and a novel nicotinic agonist on hippocampal auditory gating in two animal models. Pharmacol. Biochem. Behav. 57 (1997) 869-874
49. Suto N., Austin J.D., and Vezina P. Locomotor response to novelty predicts a rat's propensity to self-administer nicotine. Psychopharmacology (Berl) 158 (2001) 175-180
50. Tassonyi E., Charpantier E., Muller D., Dumont L., and Bertrand D. The role of nicotinic acetylcholine receptors in the mechanisms of anesthesia. Brain Res. Bull. 57 (2002) 133-150
51. Vincler M.A., and Eisenach J.C. Knock down of the alpha 5 nicotinic acetylcholine receptor in spinal nerve-ligated rats alleviates mechanical allodynia. Pharmacol. Biochem. Behav. 80 (2005) 135-143
52. Vizi E.S. Role of high-affinity receptors and membrane transporters in nonsynaptic communication and drug action in the central nervous system. Pharmacol. Rev. 52 (2000) 63-89
53. Zwart R., De Filippi G., Broad L.M., Mcphie G.I., Pearson K.H., Baldwinson T., and Sher E. 5-Hydroxyindole potentiates human alpha 7 nicotinic receptor-mediated responses and enhances acetylcholine-induced glutamate release in cerebellar slices. Neuropharmacology 43 (2002) 374-384